default author photo

Ambika G. Unnikrishnan

JSS Academy of Higher Education and Research

SCHOLARLY PAPERS

2

DOWNLOADS

57

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Performance of a Type 1 Diabetes Genetic Risk Score in a Multi-Centric Study from India and its Implications in Clinical Practice​

Number of pages: 20 Posted: 26 Feb 2026
Alagu Sankareswaran, Dimple Lavanuru, Bhanu Teja Nalluri, Shalbha Tiwari, Rashmi Nagaraj, Nagendra Khadri, Akila Prashant, Srinivas G. N. S. V. Kandula, Vedavati Purandare, Vaibhavishree Muniswamy, Navyashree Mugur Jagadeesha, Prajwal Guruswamy, Neelaveni Kudugunti, Savitha MR, Radhe Shyam Tapadia, Basavana Gowdappa, Rakesh Kumar Sahay, Ambika G. Unnikrishnan, Suraj S. Nongmaithem, Bipin Sethi and Giriraj R. Chandak
CSIR-Centre for Cellular and Molecular Biology, CSIR-Centre for Cellular and Molecular Biology, Osmania Medical College, JSS Academy of Higher Education and Research, JSS Academy of Higher Education and Research - JSS Medical College, Mysore Medical College and Research Institute, JSS Academy of Higher Education and Research - JSS Medical College, Tapadia Diagnostic Research Centre, JSS Academy of Higher Education and Research, JSS Academy of Higher Education and Research - JSS Medical College, JSS Academy of Higher Education and Research - JSS Medical College, JSS Academy of Higher Education and Research - JSS Medical College, Osmania Medical College, Mysore Medical College and Research Institute, Tapadia Diagnostic Research Centre, JSS Academy of Higher Education and Research - JSS Medical College, Osmania Medical College, JSS Academy of Higher Education and Research, CSIR-Centre for Cellular and Molecular Biology, Tapadia Diagnostic Research Centre and CSIR-Centre for Cellular and Molecular Biology
Downloads 30 (1,318,317)

Abstract:

Loading...

Type 1 Diabetes, Genetic Risk Scores, Population Genetics, Human Leucocyte Antigen, India Genetics, Clinical Implications

2.

Efficacy and Safety of Fixed-Dose Dapagliflozin-Pioglitazone in Indian Adults with Type 2 Diabetes: Results from the Randomized Phase 3 PRO-1 Trial

Number of pages: 28 Posted: 15 Oct 2025
Awadhesh Kumar Singh, Krishna Seshadri, Ambika G. Unnikrishnan, Jothydev Kesavadev, Sanjay Kalra, Shashank R Joshi, Kaushik Pandit, Rakesh Kumar Sahay, Vijay Panikar, Ambrish Mithal, Smriti Gadia and Thamburaj Anthuvan
GD Hospital & Diabetes Institute - Diabetes & Endocrinology, Apollo Hospital, JSS Academy of Higher Education and Research, Independent, Bharti Hospital, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Institute of Postgraduate Medical Education & Research (IPGMER), Osmania Medical College, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Medanta-The Medicity - Division of Endocrinology and Diabetes, USV Pvt. Ltd and S.B.Patil Institute of Management
Downloads 27 (1,372,601)

Abstract:

Loading...

Type 2 diabetes mellitu, fixed-dose combination, dapagliflozin, pioglitazone, India, Pro 1 Study, MASLD, NAFLD